The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of defined mutations in TNBC to enable patient selection for PLK1 inhibitor therapy.
 
Benjamin L Palleiko
Employment - Cielo Therapeutics
Leadership - Cielo Therapeutics
Stock and Other Ownership Interests - Cielo Therapeutics
Consulting or Advisory Role - Cielo Therapeutics
Research Funding - Cielo Therapeutics
 
Mark Miglarese
Employment - Caris Life Sciences; Cielo Therapeutics; GeneCentric
Leadership - GeneCentric
Stock and Other Ownership Interests - Array BioPharma; Caris Life Sciences; Cielo Therapeutics; GeneCentric
Consulting or Advisory Role - Cielo Therapeutics
Research Funding - Cielo Therapeutics
 
Michael G King
Leadership - Cielo Therapeutics
Stock and Other Ownership Interests - Cielo Therapeutics
Other Relationship - JMP Securities
 
Sandra L Silberman
Employment - Cielo Therapeutics
Leadership - Cielo Therapeutics
Stock and Other Ownership Interests - Cielo Therapeutics
Consulting or Advisory Role - Cielo Therapeutics
Research Funding - Cielo Therapeutics